AGR2 is also one of the genes present in the late estrogen response pathway, and our results indicate a significant positive enrichment of this pathway in luminal and normal-like BC, while basal-like and HER2-enriched tumors have a significant negative enrichment in this pathway. Here, ERBB2 is linked to breast cancer.